Biotech · Private company · Hummelstown, PA, US
Apogee Biotechnology Corporation
Track this companyFree. Adds Apogee Biotechnology Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular CarcinomaPHASE2 · WITHDRAWN · started Sep 30, 2019ClinicalTrials.gov NCT02939807 · fetched Nov 12, 2026
- ABC294640 (Opaganib) in Refractory / Relapsed Multiple MyelomaPHASE1_PHASE2 · TERMINATED · started Dec 13, 2016ClinicalTrials.gov NCT02757326 · fetched Nov 12, 2026
- ABC294640 in Treating Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01488513 · fetched Nov 12, 2026
NIH awards1
- Opaganib as a Medical Countermeasure for Gastrointestinal Acute Radiation SyndromeFiscal year 2024 · $882.7KNIH RePORTER 5R44AI179348-02 · fetched Nov 12, 2026